[Code of Federal Regulations] [Title 42, Volume 2] [Revised as of October 1, 2002] From the U.S. Government Printing Office via GPO Access [CITE: 42CFR422.202] [Page 866] TITLE 42--PUBLIC HEALTH HUMAN SERVICES PART 422--MEDICARE+CHOICE PROGRAM--Table of Contents Subpart E--Relationships With Providers Sec. 422.202 Participation procedures. (a) Notice and appeal rights. An M+C organization that operates a coordinated care plan or network MSA plan must provide for the participation of individual physicians, and the management and members of groups of physicians, through reasonable procedures that include the following: (1) Written notice of rules of participation including terms of payment, credentialing, and other rules directly related to participation decisions. (2) Written notice of material changes in participation rules before the changes are put into effect. (3) Written notice of participation decisions that are adverse to physicians. (4) A process for appealing adverse participation decisions, including the right of physicians to present information and their views on the decision. In the case of a termination or suspension of a provider contract by the M+C organization, this process must conform to the rules in Sec. 422.204(c). (b) Consultation. The M+C organization must establish a formal mechanism to consult with the physicians who have agreed to provide services under the M+C plan offered by the organization, regarding the organization's medical policy, quality assurance programs and medical management procedures and ensure that the following standards are met: (1) Practice guidelines and utilization management guidelines-- (i) Are based on reasonable medical evidence or a consensus of health care professionals in the particular field; (ii) Consider the needs of the enrolled population; (iii) Are developed in consultation with contracting physicians; and (iv) Are reviewed and updated periodically. (2) The guidelines are communicated to providers and, as appropriate, to enrollees. (3) Decisions with respect to utilization management, enrollee education, coverage of services, and other areas in which the guidelines apply are consistent with the guidelines. (c) Subcontracted groups. An M+C organization that operates an M+C plan through subcontracted physician groups must provide that the participation procedures in this section apply equally to physicians within those subcontracted groups. (d) Suspension or termination of contract. An M+C organization that operates a coordinated care plan or network MSA plan providing benefits through contracting providers must meet the following requirements: (1) Notice to physician. An M+C organization that suspends or terminates an agreement under which the physician provides services to M+C plan enrollees must give the affected individual written notice of the following: (i) The reasons for the action, including, if relevant, the standards and profiling data used to evaluate the physician and the numbers and mix of physicians needed by the M+C organization. (ii) The affected physician's right to appeal the action and the process and timing for requesting a hearing. (2) Composition of hearing panel. The M+C organization must ensure that the majority of the hearing panel members are peers of the affected physician. (3) Notice to licensing or disciplinary bodies. An M+C organization that suspends or terminates a contract with a physician because of deficiencies in the quality of care must give written notice of that action to licensing or disciplinary bodies or to other appropriate authorities. (4) Timeframes. An M+C organization and a contracting provider must provide at least 60 days written notice to each other before terminating the contract without cause. [64 FR 7981, Feb. 17, 1999, as amended at 65 FR 40324, June 29, 2000]